NasdaqGS - Delayed Quote USD

Shattuck Labs, Inc. (STTK)

10.59 +0.81 (+8.28%)
At close: April 26 at 4:00 PM EDT
11.00 +0.41 (+3.87%)
After hours: April 26 at 6:42 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for STTK

Recent News: STTK

View More
Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),

Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),
Simply Wall St. 8 days ago
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
GlobeNewswire 17 days ago
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference

Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire 25 days ago
Shattuck Labs Full Year 2023 Earnings: Beats Expectations

Shattuck Labs Full Year 2023 Earnings: Beats Expectations
Simply Wall St. last month
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors

Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
GlobeNewswire last month
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
GlobeNewswire last month
Shattuck Labs Announces Participation in Upcoming March Conferences

Shattuck Labs Announces Participation in Upcoming March Conferences
GlobeNewswire last month
Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins

Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins
PR Newswire 2 months ago
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases

Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
GlobeNewswire 2 months ago
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024
GlobeNewswire 3 months ago
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference

Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 3 months ago
Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
GlobeNewswire 4 months ago
View More

Related Tickers

FHTX Foghorn Therapeutics Inc.
5.49
+4.97%
 
CCCC C4 Therapeutics, Inc.
6.17
-1.12%
 
ALXO ALX Oncology Holdings Inc.
16.86
-0.06%
 
PRLD Prelude Therapeutics Incorporated
4.0700
+0.74%
 
ANRO Alto Neuroscience, Inc.
14.18
+0.35%
 
GYRE Gyre Therapeutics, Inc.
17.11
+4.78%
 
VIGL Vigil Neuroscience, Inc.
2.7100
+5.04%
 
NBTX Nanobiotix S.A.
5.74
-1.03%
 
TRML Tourmaline Bio, Inc.
15.68
-2.00%
 
STOK Stoke Therapeutics, Inc.
12.41
+6.16%